 In the background, as you can see, right now we are having the closing session of the head of focal point meeting which gathers the whole network of 30 countries and soon we will hear about the conclusion of the two days meeting. RATOX is a unique interactive system which links the EU drug agency to its national focal points in over 30 countries. RATOX national focal points are as such the cornerstone of the European drug monitoring and reporting system. National focal points are appointed by their national authorities. I am Tim Pfeiffer-Garsschel, the director of the German defense position for drug and drug search in Munich. One of our core tasks on national level is to pull together all available data and information describing the drug situation in Germany and to come up with reasonable interpretations and analysis of the drug situation. The national focal point provides additional capacity to assess the drug situation and ensures international exchange. This international exchange, which often takes part through the RATOX network, brings an added value as experience from other countries may be considered when addressing various questions in the drugs field. I think it has been an extremely important job and with reflections on the definition of our policies the possibility to compare the practices of the different countries, to compare the desired results and with this to offer the best political options that can always be taken. The EU is the unique region in the world which has developed a monitoring system covering 30 countries. Through the network, we have developed a collaborative effort between member states and the EU and it has been built over the years, giving very good results. Data collection, monitoring and reporting tasks that they specifically execute for us are co-financed between the agency and each EU member state. My name is Muntura Silev and I'm head of the national focal point in Bulgaria, Sofia. One of the main roles of the national focal point is to support the realization of the work plan of the EMC-DDA. So in this task it is maybe not possible to exist in the national focal point without this co-financing system and the money coming from these grants. The Swedish focal point has been able to further develop and strengthen the national processes and structures used for assessing the drug situation. In this respect the rate tax grant is highly important and it provides means to coordinate and support the prevention of drug use and associated harms. With the focal points we agree on the yearly basis on the standard reporting package with guidelines, protocols for key indicators, instructions for special topics that together form the information we receive on the yearly basis from the observatories. Quality control of the qualitative information and quantitative data is an important task. We discuss and provide a feedback on quality international focal points through different products which includes for example the quality report focusing mainly on the national reports. Twice per year the meeting gathers in this one where we discuss through workshops different topics, issues, methodological problems in order to improve the work of the observatories at national level. We're planning a trend spotting on methamphetamine probably mid-March. That's coming from concern over a period of time of amphetamine being replaced by methamphetamine in certain countries, deaths being reported, new outbreaks in certain countries and it's exactly the type of topic where we think okay we need to do some kind of rapid data gathering and get some heads together. By tracking the information on new substances we contribute to put those substances when necessary under control. The information that is collected through the focal points at national level serves as a basis for the monitoring and the evaluation of the European drug strategy.